Motley Fool Asset Management LLC Biogen Inc. Transaction History

Motley Fool Asset Management LLC

$1.46 Billion
Q2 2024

A detailed history of Motley Fool Asset Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 5,657 shares of BIIB stock, worth $983,130. This represents 0.09% of its overall portfolio holdings.

Number of Shares

5,657

Previous 4,289 31.9%

Holding current value

$983,130

Previous $924,000 41.88%

% of portfolio

0.09%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$190.52 - $236.72 $260,631 - $323,832	1,368 Added 31.9%	5,657 $1.31 Million
Q1 2024 May 08, 2024	BUY	$212.02 - $267.71 $67,846 - $85,667	320 Added 8.06%	4,289 $924,000
Q4 2023 Feb 02, 2024	SELL	$222.59 - $267.94 $5,119 - $6,162	-23 Reduced 0.58%	3,969 $1.03 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $85,615 - $96,630	338 Added 9.25%	3,992 $1.03 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $1.01 Million - $1.16 Million	3,654 New	3,654 $1.04 Million
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $40,390 - $49,075	-160 Reduced 4.25%	3,607 $998,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $4,867 - $6,711	-25 Reduced 0.66%	3,767 $1.01 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $26,255 - $31,222	-140 Reduced 3.56%	3,792 $806,000
Q1 2022 May 04, 2022	BUY	$193.77 - $244.14 $23,833 - $30,029	123 Added 3.23%	3,932 $828,000
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $14,554 - $18,705	-65 Reduced 1.68%	3,809 $914,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $72,162 - $94,107	-255 Reduced 6.18%	3,874 $1.1 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $231,028 - $369,921	892 Added 27.56%	4,129 $1.43 Million
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $98,394 - $115,275	-405 Reduced 11.12%	3,237 $906,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $64,262 - $96,731	272 Added 8.07%	3,642 $892,000
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $63,015 - $72,758	238 Added 7.6%	3,370 $962,000
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $31,039 - $41,106	120 Added 3.98%	3,132 $838,000
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $50,006 - $63,433	-186 Reduced 5.82%	3,012 $953,000
Q4 2019 Feb 11, 2020	SELL	$220.06 - $304.07 $17,604 - $24,325	-80 Reduced 2.44%	3,198 $949,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $5,870 - $6,584	-27 Reduced 0.82%	3,278 $763,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $40,787 - $44,959	186 Added 5.96%	3,305 $773,000
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $131,109 - $205,070	605 Added 24.07%	3,119 $737,000
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $26,736 - $33,864	-96 Reduced 3.68%	2,514 $757,000
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $116,229 - $151,996	396 Added 17.89%	2,610 $922,000
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $61,804 - $73,658	240 Added 12.16%	2,214 $643,000
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $513,496 - $726,254	1,974 New	1,974 $541,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Motley Fool Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motley Fool Asset Management LLC with notifications on news.

Account

Motley Fool Asset Management LLC Biogen Inc. Transaction History